Scarica l'app Stockscreener
35.18
1.90%
-0.68
Pre-mercato:
34.67
-0.51
-1.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Precedente Chiudi:
$35.86
Aprire:
$35.34
Volume 24 ore:
1.52M
Relative Volume:
1.47
Capitalizzazione di mercato:
$3.31B
Reddito:
$4.72M
Utile/perdita netta:
$-277.91M
Rapporto P/E:
-9.4316
EPS:
-3.73
Flusso di cassa netto:
$-203.56M
1 W Prestazione:
+2.87%
1M Prestazione:
+13.78%
6M Prestazione:
-2.11%
1 anno Prestazione:
-29.39%
Intervallo 1D:
$35.12
$36.31
Intervallo di 1 settimana:
$33.27
$36.31
Portata 52W:
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
Nome
Crinetics Pharmaceuticals Inc
Settore
Industria
Telefono
858-450-6464
Indirizzo
6055 LUSK BLVD., SAN DIEGO, CA
Confronta CRNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
35.18 | 3.38B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Neutral |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-11 | Iniziato | TD Cowen | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Peer Perform |
| 2025-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-06 | Iniziato | Citigroup | Buy |
| 2024-01-16 | Iniziato | Morgan Stanley | Overweight |
| 2023-12-21 | Iniziato | Jefferies | Hold |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-08-31 | Iniziato | Oppenheimer | Outperform |
| 2023-04-24 | Iniziato | Piper Sandler | Overweight |
| 2023-03-30 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-30 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-11-23 | Iniziato | Evercore ISI | Outperform |
| 2021-06-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-23 | Iniziato | ROTH Capital | Buy |
| 2019-02-14 | Iniziato | H.C. Wainwright | Buy |
| 2018-08-13 | Iniziato | JP Morgan | Neutral |
| 2018-08-13 | Iniziato | Leerink Partners | Outperform |
| 2018-08-13 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie
JP Morgan Lowers Price Target for CRNX While Maintaining Overwei - GuruFocus
JPMorgan Chase & Co. Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $52.00 - MarketBeat
CRNX FDA Catalyst Alert: Could Paltusotine Decision Reshape Endocrine Drug Market? - Nasdaq
Crinetics Pharmaceuticals (NASDAQ:CRNX) Trading Down 4.7%Time to Sell? - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Shares Purchased by Intech Investment Management LLC - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Stock Holdings Trimmed by Voya Investment Management LLC - MarketBeat
Momentum divergence signals in Crinetics Pharmaceuticals Inc. chartWeekly Investment Report & Safe Capital Growth Tips - newser.com
Rhumbline Advisers Increases Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Short interest data insights for Crinetics Pharmaceuticals Inc.2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
CEO Change: What’s the beta of Crinetics Pharmaceuticals Inc. stockLayoff News & Safe Capital Investment Plans - خودرو بانک
Visual analytics tools that track Crinetics Pharmaceuticals Inc. performanceStop Loss & Weekly Top Stock Performers List - newser.com
What Fibonacci levels say about Crinetics Pharmaceuticals Inc. reboundMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Marquis Who's Who Honors Tiffany P. Quock, PhD, MS, for Expertise in the Pharmaceutical Industry - 24-7 Press Release Newswire
Using fundamentals and technicals on Crinetics Pharmaceuticals Inc.Inflation Watch & High Return Trade Guides - newser.com
What’s next for Crinetics Pharmaceuticals Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com
Those who invested in Crinetics Pharmaceuticals (NASDAQ:CRNX) five years ago are up 151% - Yahoo Finance
Setup Watch: Can Crinetics Pharmaceuticals Inc be recession proofJuly 2025 Outlook & AI Forecasted Stock Moves - خودرو بانک
Aug Analyst Calls: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Institutional Moves & Low Risk High Reward Ideas - خودرو بانک
Treasury Yields: What are NXGL’s technical support levelsInflation Watch & Real-Time Stock Movement Alerts - خودرو بانک
Short Covering: Is Crinetics Pharmaceuticals Inc. likely to announce a buybackMarket Activity Summary & High Conviction Buy Zone Alerts - khodrobank.com
Rally Mode: What is the dividend yield of Crinetics Pharmaceuticals Inc2025 Momentum Check & Advanced Technical Analysis Signals - خودرو بانک
Is Crinetics Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Technical Overview & Weekly High Return Forecasts - newser.com
Published on: 2025-09-17 14:31:30 - خودرو بانک
Chart Watch: What is the PEG ratio of Crinetics Pharmaceuticals IncQuarterly Profit Summary & Expert Curated Trade Setups - خودرو بانک
Sell Signal: Should value investors consider Crinetics Pharmaceuticals IncPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Crinetics Pharmaceuticals Inc. stock trendline breakdownExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-09-16 16:37:44 - newser.com
Investment Report: What is the dividend yield of Crinetics Pharmaceuticals IncShort Setup & Reliable Volume Spike Trade Alerts - خودرو بانک
Performance Recap: Is Crinetics Pharmaceuticals Inc a stock for growth or value investorsTrade Analysis Summary & Free Reliable Trade Execution Plans - خودرو بانک
Death Cross: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)Market Growth Review & Real-Time Chart Breakout Alerts - خودرو بانک
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Down 2.7%Time to Sell? - MarketBeat
Using portfolio simulators with Crinetics Pharmaceuticals Inc. included2025 Market Trends & Community Consensus Stock Picks - newser.com
Market Overview: Can SCE Trust VI Preferred Security continue delivering strong returnsLayoff News & Capital Efficiency Focused Strategies - خودرو بانک
Guidance Update: Can Crinetics Pharmaceuticals Inc. outperform under higher oil pricesTrade Volume Summary & Weekly Sector Rotation Insights - خودرو بانک
Volume Report: Is Crinetics Pharmaceuticals Inc. stock a good dividend stock2025 Pullback Review & Long-Term Investment Growth Plans - خودرو بانک
Bearish Setup: Is Crinetics Pharmaceuticals Inc stock a top performer YTD2025 Market Sentiment & Advanced Technical Signal Analysis - خودرو بانک
Exome Asset Management LLC Purchases Shares of 51,295 Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Are Investors Undervaluing Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) By 28%? - 富途牛牛
9 of the Fastest-Growing Biotech Stocks Under $10 Billion - TIKR.com
Dupont Capital Management Corp Sells 561 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - 富途牛牛
Parkman Healthcare Partners LLC Purchases 12,807 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
62,475 Stock Options at $35/Share: Crinetics Pharmaceuticals Awards Inducement Grants to New Hires - Stock Titan
Cormorant Asset Management LP Has $20.12 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Crinetics Pharmaceuticals Inc Azioni (CRNX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pizzuti Dana | Chief Med and Dev Officer |
Sep 02 '25 |
Sale |
32.10 |
5,000 |
160,500 |
96,270 |
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):